Lanean...
Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
This retrospective cohort study investigated whether metformin may reduce gastric cancer risk by using the reimbursement databases of the Taiwan's National Health Insurance. Patients with type 2 diabetes diagnosed during 1999-2005 and newly treated with metformin (n=287971, “ever users of metfo...
Gorde:
| Argitaratua izan da: | Aging (Albany NY) |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Impact Journals LLC
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5032687/ https://ncbi.nlm.nih.gov/pubmed/27587088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.101019 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|